Clean Science

₹1300 10.8 | 0.8%

WEBSITE BSE:543318 NSE : CLEAN 10 May, 16:01

Market Cap ₹13813 Cr.

Stock P/E 54.3

P/B 12

Current Price ₹1300

Book Value ₹ 108.5

Face Value 1

52W High ₹1622.4

Dividend Yield 0.38%

52W Low ₹ 1280

Edit Ratio

Clean Science Research see more...

Overview Inc. Year: 2003Industry: Chemicals

Clean Science and Technology Limited engages within the research, improvement, manufacture, and marketing of speciality chemical compounds in India and the world over. The organisation offers guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, anisole, mono methyl ether of hydroquinone, L-ascorbyl palmitate, and N,N'-dicyclohexylcarbodiimide. It serves purchaser and business markets. The organization incorporated in 2003 and is primarily based in Pune, India.

Clean Science Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Clean Science Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	153	181	205	234	248	237	217	188	181	195
Other Income	9	7	7	2	3	13	13	13	6	8
Total Income	162	188	212	236	250	250	229	202	187	203
Total Expenditure	84	105	121	143	150	129	112	112	106	108
Operating Profit	77	84	91	93	100	121	118	90	81	94
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	6	6	7	8	9	9	10	11	11	11
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	71	78	84	85	92	112	108	79	69	83
Provision for Tax	18	20	22	22	24	28	27	20	17	20
Profit After Tax	54	58	62	63	68	84	81	59	52	63
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	54	58	62	63	68	84	81	59	52	63
Adjusted Earnings Per Share	5	5.5	5.9	5.9	6.4	7.9	7.6	5.5	4.9	5.9

Clean Science Profit & Loss

#(Fig in Cr.)	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	241	393	419	512	685	936	781
Other Income	5	11	11	26	30	30	40
Total Income	246	405	430	538	715	966	821
Total Expenditure	167	257	234	253	385	533	438
Operating Profit	78	148	196	285	330	432	383
Interest	1	0	0	0	0	1	0
Depreciation	8	11	14	17	25	36	43
Exceptional Income / Expenses	0	0	0	0	0	0	0
Profit Before Tax	70	137	182	267	305	396	339
Provision for Tax	21	39	43	69	76	100	84
Profit After Tax	49	98	140	198	228	295	255
Adjustments	0	0	0	0	0	0	0
Profit After Adjustments	49	98	140	198	228	295	255
Adjusted Earnings Per Share	4.3	8.6	13.1	18.7	21.5	27.8	23.9

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	37%	0%	19%	0%
Operating Profit CAGR	31%	0%	24%	0%
PAT CAGR	29%	0%	25%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-13%	NA%	NA%	NA%
ROE Average	33%	38%	40%	38%
ROCE Average	45%	51%	53%	51%

Clean Science Balance Sheet

#(Fig in Cr.)	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	188	272	342	540	768	1010
Minority's Interest	0	0	0	0	0	0
Borrowings	0	0	0	0	0	0
Other Non-Current Liabilities	10	14	11	18	21	26
Total Current Liabilities	38	41	77	102	135	116
Total Liabilities	236	327	430	660	925	1152
Fixed Assets	102	127	166	186	296	460
Other Non-Current Assets	9	8	7	79	59	61
Total Current Assets	125	193	257	395	559	630
Total Assets	236	327	430	660	925	1152

Clean Science Cash Flow

#(Fig in Cr.)	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	6	30	9	9	9	58
Cash Flow from Operating Activities	45	85	160	193	127	279
Cash Flow from Investing Activities	-18	-95	-106	-187	-79	-270
Cash Flow from Financing Activities	-5	-11	-55	-6	-0	-55
Net Cash Inflow / Outflow	22	-21	-2	0	49	-45
Closing Cash & Cash Equivalent	30	9	9	9	58	12

Clean Science Ratios

#	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	4.32	8.62	13.14	18.68	21.51	27.78
CEPS(Rs)	4.99	9.59	14.43	20.3	23.86	31.18
DPS(Rs)	3	7.5	9	2.5	3.25	5
Book NAV/Share(Rs)	16.58	24.02	32.2	50.81	72.3	94.95
Core EBITDA Margin(%)	30.44	34.74	44.26	50.58	43.83	43.01
EBIT Margin(%)	29.18	34.8	43.58	52.23	44.57	42.34
Pre Tax Margin(%)	28.95	34.72	43.48	52.16	44.5	42.28
PAT Margin (%)	20.15	24.83	33.3	38.71	33.36	31.54
Cash Profit Margin (%)	23.28	27.64	36.57	42.07	37	35.4
ROA(%)	20.71	34.66	36.87	36.41	28.84	28.43
ROE(%)	26.03	42.47	45.47	45	34.95	33.23
ROCE(%)	37.58	59.11	59	60.5	46.65	44.55
Receivable days	59.65	46.14	56.41	51.31	60.69	58.46
Inventory Days	43.67	30.66	31.17	31.16	37.58	38.41
Payable days	84.98	51.96	81.94	142.77	132.49	102.25
PER(x)	0	0	0	0	92.65	45.51
Price/Book(x)	0	0	0	0	27.57	13.32
Dividend Yield(%)	0	0	0	0	0.16	0.4
EV/Net Sales(x)	-0.11	-0.01	-0.01	-0.01	30.8	14.34
EV/Core EBITDA(x)	-0.35	-0.04	-0.03	-0.02	63.9	31.04
Net Sales Growth(%)	0	63.13	6.62	22.21	33.66	36.64
EBIT Growth(%)	0	93.28	33.51	46.46	14.05	29.8
PAT Growth(%)	0	99.72	42.98	42.07	15.18	29.18
EPS Growth(%)	0	99.72	52.45	42.1	15.18	29.16
Debt/Equity(x)	0	0.01	0.01	0	0	0
Current Ratio(x)	3.31	4.68	3.34	3.87	4.15	5.46
Quick Ratio(x)	2.54	3.78	2.89	3.36	3.49	4.51
Interest Cover(x)	125.56	411.02	443.51	820.94	687.48	710.02
Total Debt/Mcap(x)	0	0	0	0	0	0

Clean Science Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	78.51	78.51	78.51	78.5	78.5	78.5	74.99	74.98	74.98	74.98
FII	5.05	5.18	4.43	4.43	3.99	3.99	5.84	6	5.92	5.88
DII	4.28	4.01	4.51	4.48	4.64	4.76	6.4	5.23	5.14	5.04
Public	12.16	12.29	12.55	12.59	12.87	12.75	12.77	13.79	13.97	14.1
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	8.34	8.34	8.34	8.34	8.34	8.34	7.97	7.97	7.97	7.97
FII	0.54	0.55	0.47	0.47	0.42	0.42	0.62	0.64	0.63	0.63
DII	0.46	0.43	0.48	0.48	0.49	0.51	0.68	0.56	0.55	0.54
Public	1.29	1.31	1.33	1.34	1.37	1.35	1.36	1.46	1.48	1.5
Others	0	0	0	0	0	0	0	0	0	0
Total	10.62	10.62	10.62	10.62	10.62	10.62	10.62	10.62	10.62	10.63

Pros

Company has delivered good profit growth of 24% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 38%
Debtor days have improved from 132.49 to 102.25days.
Company is almost debt free.

Cons

Stock is trading at 12 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.